Page last updated: 2024-10-23

berberine and Leishmaniasis, Cutaneous

berberine has been researched along with Leishmaniasis, Cutaneous in 1 studies

Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Calvo, A1
Moreno, E1
Aldalur, I1
Sanmartín, C1
Larrea, E1
González-Peñas, E1
Irache, JM1
Espuelas, S1

Other Studies

1 other study available for berberine and Leishmaniasis, Cutaneous

ArticleYear
Effect of topical berberine in murine cutaneous leishmaniasis lesions.
    The Journal of antimicrobial chemotherapy, 2022, 03-31, Volume: 77, Issue:4

    Topics: Administration, Topical; Animals; Antiprotozoal Agents; Berberine; Leishmania major; Leishmaniasis,

2022